The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Antidepressant Monotherapy vs Sequential Pharmacotherapy and Mindfulness-Based Cognitive Therapy, or Placebo, for Relapse Prophylaxis in Recurrent Depression
Open accessAbstract
CONTEXT: Mindfulness-based cognitive therapy (MBCT) is a group-based psychosocial intervention designed to enhance self-management of prodromal symptoms associated with depressive relapse. OBJECTIVE: To compare rates of relapse in depressed patients in remission receiving MBCT against maintenance antidepressant pharmacotherapy, the current standard of care. DESIGN: Patients who met remission criteria after 8 months of algorithm-informed antidepressant treatment were randomized to receive maintenance antidepressant medication, MBCT, or placebo and were followed up for 18 months. SETTING: Outpatient clinics at the Centre for Addiction and Mental Health, Toronto, Ontario, Canada, and St Joseph's Healthcare, Hamilton, Ontario. PARTICIPANTS: One hundred sixty patients aged 18 to 65 years meeting DSM-IV criteria for major depressive disorder with a minimum of 2 past episodes. Of these, 84 achieved remission (52.5%) and were assigned to 1 of the 3 study conditions. INTERVENTIONS: Patients in remission discontinued their antidepressants and attended 8 weekly group sessions of MBCT, continued taking their therapeutic dose of antidepressant medication, or discontinued active medication and were switched to placebo. MAIN OUTCOME MEASURE: Relapse was defined as a return, for at least 2 weeks, of symptoms sufficient to meet the criteria for major depression on module A of the Structured Clinical Interview for DSM-IV. RESULTS: Intention-to-treat analyses showed a significant interaction between the quality of acute-phase remission and subsequent prevention of relapse in randomized patients (P = .03). Among unstable remitters (1 or more Hamilton Rating Scale for Depression score >7 during remission), patients in both MBCT and maintenance treatment showed a 73% decrease in hazard compared with placebo (P = .03), whereas for stable remitters (all Hamilton Rating Scale for Depression scores ≤7 during remission) there were no group differences in survival. CONCLUSIONS: For depressed patients achieving stable or unstable clinical remission, MBCT offers protection against relapse/recurrence on a par with that of maintenance antidepressant pharmacotherapy. Our data also highlight the importance of maintaining at least 1 long-term active treatment in unstable remitters.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For stable remitters (all HAM-D scores ≥ 7 during remission), there were no differences in relapse of absence of withdrawal symptoms measured a er antidepressants were tapered (relapse rates: 50% discontinuation group, 59% antidepressant group; HR not reported; P = 0.49).”
From Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults (2021) · cites this paper as Segal 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among unstable remitters (one or more with HAM-D score ≥ 7 during remission), participants in the discontinuation group showed higher risk of relapse compared with those in the continuation group (relapse rates: discontinuation group 71%, 27% antidepressant; HR 4.16, 95% CI 1.12 to 14.3; P = 0.03).”
From Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults (2021) · cites this paper as Segal 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the second study, 39 84 patients with recurrent depression who had remitted on antidepressants were randomly assigned to MBCT-TS, maintenance antidepressants, or pill placebo.Relapse or recurrence rates noted over 18 months of follow-up did not diff er for MBCT-TS (28%, n=5/18) and maintenance antidepressants (27%, n=3/11), but both were lower than with placebo (71%, n=10/14).39”
From Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial (2015) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Psychotherapy undertaken during a relapse prevention phase tends to focus on addressing any residual symptoms of depression, which have been shown to increase the chances of a relapse, on affect regulation and on self management skills needed to promote recovery (Segal 2010).”
From Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents (2012) · cites this paper as Segal 2010
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“and unstable remitters (28% for MBCT and discontinuation, 27% for continuation of antidepressant; HR 1.07, 95% CI 0.25 to 4.49; P = 0.93).”
From Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults (2021) · cites this paper as Segal 2010
The cited source says what the claim attributes to it.
In the citing paper
“However, there was no difference between discontinuation with MBCT and continuation of antidepressants in stable remitters (62% for MBCT and discontinuation, 59% for continuation of antidepressant; P = 0.77)”
From Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults (2021) · cites this paper as Segal 2010
The cited source says what the claim attributes to it.
In the citing paper
“Before this study, only two small studies 10,39 had compared MBCT-TS with maintenance antidepressants (panel).”
The cited source says what the claim attributes to it.
In the citing paper
“We pooled our trial data with the equivalent MBCT-TS and maintenance antidepressant medication groups of the previous two randomised controlled trials (n=123 10 and n=54 39 ), and used the equivalent 60-week follow-up point available across all three studies.The combined relative risk ratio of MBCT-TS versus maintenance antidepressants was 0•76 (95% CI 0•59-0•98), a risk reduction of 24%.There was”
The cited source says what the claim attributes to it.
In the citing paper
“The relapse prevention effect was not significant in the other two studies [87, 89].”
From Psychological interventions to prevent relapse in anxiety and depression: A systematic review and meta-analysis (2022) · cites this paper as [89]
The cited source says what the claim attributes to it.
In the citing paper
“Fava et al. [87] and Fava et al. [88] both had a follow-up period of 29 months and Segal et al. [89] had a follow up of 18 months.”
From Psychological interventions to prevent relapse in anxiety and depression: A systematic review and meta-analysis (2022) · cites this paper as [89]
The cited source says what the claim attributes to it.
In the citing paper
“However, one trial found it to be about as effective as long-term treatment with an antidepressant (Segal et al., 2010)”
From Prevention of Relapse and Recurrence in Adults with Major Depressive Disorder: Systematic Review and Meta-Analyses of Controlled Trials (2016) · cites this paper as Segal et al., 2010
The cited source says what the claim attributes to it.
In the citing paper
“evidence has accrued to suggest that MBCT may only be efficacious or advantageous over other forms of aftercare for those patients with greater vulnerability, in the form of recurrent depression, 97,98 unstable remission, 99,100 or a history of childhood trauma 98”
From Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016) · cites this paper as [99]
In the citing paper
“MBIs also evidence unevenness in preventing relapse of MDD (e.g., 3+ versus >3 lifetime episodes) [30]”
From All together now: utilizing common functional change principles to unify cognitive behavioral and mindfulness-based therapies (2019) · cites this paper as [30]
In the citing paper
“In all those studies that compared MBCT to antidepressant medication, no overall significant advantage to MBCT was demonstrated 12,[20][21][22]35 and no advantage was observed by adding MBCT to antidepressant medication.20”
From Mindfulness-based cognitive therapy for prevention and time to depressive relapse: Systematic review and network meta-analysis (2021) · cites this paper as [12]
In the citing paper
“However, long-term follow-up studies also show that both MBCT and antidepressants can each confer enduring positive effects and thus MBCT may offer an alternative to medication in some cases.12,34,35”
From Mindfulness-based cognitive therapy for prevention and time to depressive relapse: Systematic review and network meta-analysis (2021) · cites this paper as [12]
In the citing paper
“In addition, MBCT appears to be at least as effective as mADM (Kuyken et al., 2008;Kuyken et al., 2015;Segal et al., 2010).”
From Adding mindfulness-based cognitive therapy to maintenance antidepressant medication for prevention of relapse/recurrence in major depressive disorder: Randomised controlled trial (2015) · cites this paper as Segal et al., 2010
In the citing paper
“Studies comparing MBCT with mADM (Kuyken et al., 2008;Segal et al., 2010;Kuyken et al., 2015) did not show any differences between the effectiveness of MBCT and that of mADM either.”
From Adding mindfulness-based cognitive therapy to maintenance antidepressant medication for prevention of relapse/recurrence in major depressive disorder: Randomised controlled trial (2015) · cites this paper as Segal et al., 2010
In the citing paper
“but the relapse/recurrence rate in our medication only condition of 37% was substantially lower than that of comparable studies (Kuyken et al., 2008;Kuyken et al., 2015;Segal et al., 2010).”
From Adding mindfulness-based cognitive therapy to maintenance antidepressant medication for prevention of relapse/recurrence in major depressive disorder: Randomised controlled trial (2015) · cites this paper as Segal et al., 2010
In the citing paper
“The overall teacher competency in our study was lower than in previous studies (Kuyken et al., 2008;Kuyken et al., 2015;Segal et al., 2010)”
From Adding mindfulness-based cognitive therapy to maintenance antidepressant medication for prevention of relapse/recurrence in major depressive disorder: Randomised controlled trial (2015) · cites this paper as Segal et al., 2010
In the citing paper
“residual symptoms (Segal et al., 2010)”
From Adding mindfulness-based cognitive therapy to maintenance antidepressant medication for prevention of relapse/recurrence in major depressive disorder: Randomised controlled trial (2015) · cites this paper as Segal et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Statistical methods for rates and proportions
Fleiss, J., Levin, B., & Paik, M. (1973) · Biometrics · doi:10.2307/2529186 · Cited by 21,632
Statistical Methods for Rates and Proportions
Fleiss, J. L., Levin, B., & Paik, M. C. (2003) · Wiley Series in Probability and Statistics · doi:10.1002/0471445428 · Cited by 18,646
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,269
Breslow, N. E., Cox, D. R., & Oakes, D. (1985) · Biometrics · doi:10.2307/2530888 · Cited by 4,381
Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829
(2001) · Cited by 3,666
Self-citationPrevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy.
Teasdale, J. D., Segal, Z. V., Williams, J. M. G., Ridgeway, V. A., Soulsby, J. M., & Lau, M. A. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.4.615 · Cited by 3,236
Self-citation(1997) · American Psychiatric Press eBooks · Cited by 3,056
Frank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959
Transduction of psychosocial stress into the neurobiology of recurrent affective disorder
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.8.999 · Cited by 1,848
Keller, M. B. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800180050009 · Cited by 1,643
Ostwald, P. F. (1960) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1960.14.4.817 · Cited by 1,422
Ma, S. H., & Teasdale, J. D. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.1.31 · Cited by 1,390
Three-Year Outcomes for Maintenance Therapies in Recurrent Depression
Frank, E. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810240013002 · Cited by 1,294
Sample-Size Formula for the Proportional-Hazards Regression Model
Schoenfeld, D. (1983) · Biometrics · doi:10.2307/2531021 · Cited by 1,115
Goldapple, K., Segal, Z., Garson, C., Lau, M., Bieling, P., Kennedy, S., & Mayberg, H. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.34 · Cited by 1,068
Self-citationDistributed Disturbances in Brain Structure and Function in Schizophrenia
Lewis, D. A. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.1 · Cited by 971
How does mindfulness-based cognitive therapy work?
Kuyken, W., Watkins, E., Holden, E., White, K., Taylor, R. S., Byford, S., Evans, A., Radford, S., Teasdale, J. D., & Dalgleish, T. (2010) · Behaviour Research and Therapy · doi:10.1016/j.brat.2010.08.003 · Cited by 809
Statistical Methods for Rates and Proportions.
Fielding, A., & Fleiss, J. L. (1974) · Journal of the Royal Statistical Society Series A (General) · doi:10.2307/2344565 · Cited by 772
Mindfulness-based cognitive therapy to prevent relapse in recurrent depression.
Kuyken, W., Byford, S., Taylor, R. S., Watkins, E., Holden, E., White, K., Barrett, B., Byng, R., Evans, A., Mullan, E., et al. (2008) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0013786 · Cited by 770
Psychosocial Disability During the Long-term Course of Unipolar Major Depressive Disorder
Judd, L. L., Akiskal, H. S., Zeller, P. J., Paulus, M., Leon, A. C., Maser, J. D., Endicott, J., Coryell, W., Kunovac, J. L., Mueller, T. I., et al. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.4.375 · Cited by 593
Minding one’s emotions: Mindfulness training alters the neural expression of sadness.
Farb, N. A. S., Anderson, A. K., Mayberg, H., Bean, J., McKeon, D., & Segal, Z. V. (2010) · Emotion · doi:10.1037/a0017151 · Cited by 521
Self-citationPrevention of Recurrent Depression With Cognitive Behavioral Therapy: Preliminary Findings
Fava, G. A., Rafanelli, C., Grandi, S., Conti, S., & Belluardo, P. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.9.816 · Cited by 491
Cognitive reactivity to sad mood provocation and the prediction of depressive relapse
Segal, Z. V., Kennedy, S., Gemar, M., Hood, K., Pedersen, R., & Buis, T. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.7.749 · Cited by 470
Self-citationNierenberg, A. A., Husain, M. M., Trivedi, M. H., Fava, M., Warden, D., Wisniewski, S. R., Miyahara, S., & Rush, A. J. (2010) · Psychological Medicine · doi:10.1017/s0033291709006011 · Cited by 458
Judd, L. L., Paulus, M. J., Schettler, P. J., Akiskal, H. S., Endicott, J., Leon, A. C., Maser, J. D., Mueller, T., Solomon, D. A., & Keller, M. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.9.1501 · Cited by 458
Segal, Z. V., Teasdale, J. D., Williams, J. M., & Gemar, M. C. (2002) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.320 · Cited by 432
Self-citationSix-Year Outcome of Cognitive Behavior Therapy for Prevention of Recurrent Depression
Fava, G. A., Ruini, C., Rafanelli, C., Finos, L., Conti, S., & Grandi, S. (2004) · American Journal of Psychiatry · doi:10.1176/ajp.161.10.1872 · Cited by 392 · cited 1×
“(%) 13 (8) 6 (7) 7 (9) Any Axis I comorbidity, No.”
Mindfulness-based cognitive therapy for depression: A new approach for preventing relapse
Barnhofer, T. (2002) · Zeitschrift für Klinische Psychologie und Psychotherapie · doi:10.1026//1616-3443.31.4.298 · Cited by 338
Trivedi, M. H., Rush, A. J., Crismon, M. L., Kashner, T. M., Toprac, M. G., Carmody, T. J., Key, T., Biggs, M. M., Shores‐Wilson, K., Witte, B. P., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.669 · Cited by 310
Pedersen, L. H., Henriksen, T., Vestergaard, M., Olsen, J., & Bech, B. H. (2009) · BMJ · doi:10.1136/bmj.b3569 · Cited by 296
Jarrett, R., Kraft, D., Doyle, J., Foster, B. M., Eaves, G., & Silver, P. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.4.381 · Cited by 278
FAWCETT, J. A., Epstein, P., Fiester, S. J., Elkin, I., & Autry, J. H. (1987) · PubMed · Cited by 273
Raue, P. J., Schulberg, H. C., Heo, M., Klimstra, S., & BRUCE, M. L. (2009) · Psychiatric Services · doi:10.1176/appi.ps.60.3.337 · Cited by 225
Bondolfi, G., Jermann, F., der Linden, M. V., Gex-Fabry, M., Bizzini, L., Rouget, B. W., Myers-Arrazola, L., Gonzalez, C., Segal, Z., Aubry, J.-M., et al. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.07.007 · Cited by 223
Self-citationRaue, P. J., Schulberg, H. C., Heo, M., et al. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.3.337 · Cited by 180
Does Study Design Influence Outcome?
Rutherford, B. R., Sneed, J. R., & Roose, S. P. (2009) · Psychotherapy and Psychosomatics · doi:10.1159/000209348 · Cited by 162
Simon, G. E., Korff, M. V., Rutter, C. M., & Peterson, D. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.4.395 · Cited by 160
The SSRI discontinuation syndrome
Haddad, P. M. (1998) · Journal of Psychopharmacology · doi:10.1177/026988119801200311 · Cited by 123
Continuation and Maintenance Use of Antidepressants in Recurrent Depression
Bockting, C. L. H., ten Doesschate, M. C., Spijker, J., Spinhoven, P., Koeter, M. W. J., & Schene, A. H. (2008) · Psychotherapy and Psychosomatics · doi:10.1159/000110056 · Cited by 121
Keller, M. B., Trivedi, M. H., Thase, M. E., Shelton, R. C., Kornstein, S. G., Nemeroff, C. B., Friedman, E. S., Gelenberg, A. J., Kocsis, J. H., Dunner, D. L., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0812 · Cited by 116
Burden of phase-specific sexual dysfunction with SSRIs☆
Clayton, A. H., KELLER, A., & McGarvey, E. L. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.12.007 · Cited by 114
Bockting, C. L. H., Spinhoven, P., Wouters, L. F., Koeter, M. W. J., Schene, A. H., & DELTA Study Group (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04784blu · Cited by 113
Six-Year Outcome of Cognitive Behavior Therapy for Prevention of Recurrent Depression
Fava, G. A. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.10.1872 · Cited by 112
Michalak, J., Heidenreich, T., Meibert, P., & Schulte, D. (2008) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0b013e31817d0546 · Cited by 107
Sequential Treatment of Mood and Anxiety Disorders
Fava, G. A., Ruini, C., & Rafanelli, C. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1108 · Cited by 103
Clinical management of antidepressant discontinuation.
Rosenbaum, J. F., & Zajecka, J. (1997) · PubMed · Cited by 99
Adherence to continuation and maintenance antidepressant use in recurrent depression
ten Doesschate, M. C., Bockting, C. L. H., & Schene, A. H. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.07.011 · Cited by 86
Tachyphylaxis in unipolar major depressive disorder
Solomon, D. A., Leon, A. C., Mueller, T. I., Coryell, W., Teres, J. J., Posternak, M. A., Judd, L. L., Endicott, J., & Keller, M. B. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0302 · Cited by 71
Fifty Years with the Hamilton Scales for Anxiety and Depression
Bech, P. (2009) · Psychotherapy and Psychosomatics · doi:10.1159/000214441 · Cited by 71
Venlafaxine Versus Placebo in the Preventive Treatment of Recurrent Major Depression
Montgomery, S., Entsuah, R., Hackett, D., Kunz, N. R., Rudolph, R. L., & Venlafaxine 335 Study Group (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0307 · Cited by 69
Dew, M. A., Reynolds, C. F., Mulsant, B. H., Frank, E., Houck, P. R., Mazumdar, S., Begley, A. E., & Kupfer, D. J. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00280-9 · Cited by 46
Prevention of Relapse in Residual Depression by Cognitive Therapy: A Controlled Trial
Paykel, E. S., Scott, J., Teasdale, J. D., Johnson, A. L., Garland, A., Moore, R., Jenaway, A., Cornwall, P. L., Hayhurst, H., Abbott, R., et al. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.9.829 · Cited by 20
Relapse Prevention and Residual Symptoms
Bech, P., Lönn, S. L., & Overø, K. F. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04749blu · Cited by 19
Dungan, J. S. (2010) · Yearbook of Obstetrics Gynecology and Women s Health · doi:10.1016/s1090-798x(10)79317-6 · Cited by 18
Strunk, D. R., Stewart, M., Hollon, S. D., DeRubeis, R. J., FAWCETT, J. A., Amsterdam, J. D., & Shelton, R. C. (2009) · Psychological Medicine · doi:10.1017/s0033291709991553 · Cited by 15
Ballenger, J. C. (2009) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)79087-x · Cited by 14
(1999) · Topics in Pain Management · doi:10.1097/00587875-199906000-00001 · Cited by 5
Research works printed but not linked: 2
- [17]17. First, M.; Spitzer, R.; Gibbon, M.; Williams, J. Structured clinical interview for Axis I DSM IV disorders--Patient edition. Washington, DC: American Psychiatric Press Inc; 1994.
- [28]28. Farb N, Anderson A, Mayberg H, Bean J, McKeon D, Segal Z. Mindfulness training is associated with altered neural response to sad mood provocation. Emotion. In press.
Cited by
Sorted by citations
Meditation Programs for Psychological Stress and Well-being: A Systematic Review and Meta-analysis
Goyal, M., Singh, S., Sibinga, E. M. S., Gould, N. F., Rowland-Seymour, A., Sharma, R., Berger, Z., Sleicher, D., Maron, D. D., Shihab, H. M., et al. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.13018 · Cited by 2,380
Creswell, J. D. (2017) · Annual Review of Psychology · doi:10.1146/annurev-psych-042716-051139 · Cited by 1,702
Van Dam, N. T., van Vugt, M. K., Vago, D. R., Schmalzl, L., Saron, C. D., Olendzki, A., Meissner, T., Lazar, S. W., Kerr, C. E., Gorchov, J., et al. (2018) · Perspectives on Psychological Science · doi:10.1177/1745691617709589 · Cited by 1,506
Computational psychiatry as a bridge from neuroscience to clinical applications
Huys, Q. J. M., Maia, T. V., & Frank, M. J. (2016) · Nature Neuroscience · doi:10.1038/nn.4238 · Cited by 1,002
Advances in cognitive theory and therapy: The generic cognitive model
Beck, A. T., & Haigh, E. A. P. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153734 · Cited by 1,055
Metadata
- Authors
- Segal, Z. V., Bieling, P., Young, T., MacQueen, G., Cooke, R., Martin, L., Bloch, R., & Levitan, R. D.
- Affiliations
- Centre for Addiction and Mental Health (CA)
- University of British Columbia (CA)
- Corresponding author
- Segal, Zindel V.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2010-12-06
- Volume
- 67
- Issue
- 12
- Pages
- 1256
- ISSN
- 0003-990X (ISSN-L)
- PMC
- PMC3311113
- OpenAlex
- W2153222062
- Cited by
- 429
- References
- 59
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 10 · 2023: 16 · 2022: 14 · 2021: 18 · 2020: 31 · 2019: 29 · 2018: 23 · 2017: 20 · 2016: 44 · 2015: 51 · 2014: 35 · 2013: 37 · 2012: 52
- FWCI
- 28.64
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (R01MH066992)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- recurrent depression, relapse prevention, mindfulness-based cognitive therapy, antidepressant monotherapy, major depressive disorder, prodromal symptoms
- MeSH terms
- Adolescent, Adult, Aged, Antidepressive Agents, Attention, Combined Modality Therapy, Major Depressive Disorder, Drug Administration Schedule, Female, Follow-Up Studies, Humans, Male, Middle Aged, Ontario, Outpatients, Psychiatric Status Rating Scales, Psychotherapy, Group, Cognitive Behavioral Therapy, Treatment Outcome, Diagnostic and Statistical Manual of Mental Disorders, Secondary Prevention, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
